|
KMID : 1148920220560050236
|
|
Nuclear Medicine and Molecular Imaging
2022 Volume.56 No. 5 p.236 ~ p.244
|
|
|
Comparative Role of 18F-DOPA PET/CT and 131I-MIBG Scintigraphy in Neuroblastoma and Application of Curie and SIOPEN Scoring Systems in 18F-DOPA PET/CT
|
|
Hemrom Angel
Arora Geetanjali
Damle Nishikant Avinash
Bal Chandrasekhar
|
|
|
Abstract
|
|
|
Purpose: Neuroblastoma (NB) is childhood’s most common extracranial solid malignancy. We have compared two imaging modalities, 131I-MIBG and 18F-DOPA PET/CT, to evaluate NB. Also, feasibility of the application of standardised scoring systems, SIOPEN and Curie scoring systems, in 18F-DOPA PET/CT was explored.
Methods: Patients with histopathology-proven NB underwent 131I-MIBG (planar and SPECT/CT) and 18F-DOPA PET/CT scans, as per standard imaging protocols. Duration between scans ranged from 1 to 30 days (median?=?8 days). Number of lesions in Curie and SIOPEN scoring systems applied on both modalities was compared.
Results: Forty-six patients were included (M:F?=?29:17) with a median age of 36 months. Both 131I-MIBG and 18F-DOPA scans were positive in 39 patients and negative in four patients. 18F-DOPA PET/CT was positive in additional three patients, in which 131I-MIBG was negative (p?=?0.25). Overall, 18F-DOPA identified significantly greater number of lesions than 131I-MIBG, especially metastatic skeletal lesions (p??0.05). CS and SIOPEN scores were significantly higher in bone marrow-positive patients.
Conclusion: 18F-DOPA PET/CT detected more lesions than 131I-MIBG but had little impact on staging of the disease. For evaluation of NB, both scans can be used interchangeably as per the availability. Furthermore, both SIOPEN and Curie scoring systems, standardised for MIBG, can also be used to semi-quantify disease extent in 18F-DOPA PET/CT.
|
|
|
KEYWORD
|
|
|
Neuroblastoma, 18F-DOPA PET/CT, 131I-MIBG, Curie score, SIOPEN
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|